Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapy

Breast Disease · Published 2025-11-01 · DOI 10.1177/15581551251403784

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1177/15581551251403784

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• The role of platelet rich plasma enriched fat graft for correction of deformities after conservative breast surgery · Breast Disease · 2024 · Same journal
• The quality of life assessment of breast cancer patients · Breast Disease · 2024 · Same journal
• Genomic analysis of breast cancer patients from Kerala: A novel BRCA1 mutation detected · Breast Disease · 2023 · Same journal
• In-silico prediction of anti-breast cancer activity of ginger (Zingiber officinale) using machine learning techniques · Breast Disease · 2024 · Same journal
• Circulating tumor cells as a clinical, diagnostic, and prognostic biomarker in breast cancer · Breast Disease · 2025 · Same journal
• What is known about patient-centered care application in post-surgical breast cancer patients? · Breast Disease · 2023 · Same journal
• Eribulin in metastatic breast cancer: Real world data · Breast Disease · 2023 · Same journal
• Granular cell tumour of the breast: A case report · Breast Disease · 2023 · Same journal
• Development of neuro-Behcet’s disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy: A case report · Breast Disease · 2024 · Same journal
• Synchronous primary breast angiosarcoma with invasive ductal carcinoma · Breast Disease · 2024 · Same journal